描述 |
Desonide是非氟化皮质类固醇抗炎剂,能作用于糖皮质激素受体。 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
相关类别 |
|
||||||||||||
溶解度 |
体外:
在DMSO中10mM
|
||||||||||||
储备液 |
|
||||||||||||
存储 |
|
||||||||||||
运输 |
室温;可能会有所不同 |
||||||||||||
SMILES |
C[C@@]12[C@@]3(C(CO)=O)[C@@](OC(C)(O3)C)([H])C[C@@]1([H])[C@]4([H])CCC5=CC(C=C[C@]5(C)[C@@]4([H])[C@@H](O)C2)=O |
||||||||||||
参考文献 |
[3]. Parish, D. and N. Scheinfeld, Desonide foam: a review. Drugs Today (Barc), 2008. 44(1): p. 55-62.
|
||||||||||||
相关活性 小分子 |
氢化可的松 | 米非司酮 | 皮质酮 | 泼尼松 | 原人参三醇 | 氟替卡松丙酸酯 | 曲安西龙 | 可的松 | AL 082D06 | 糖皮质激素受体激动剂 | Mapracorat | 环索奈德 | 丙酸倍氯米松 | 丙酸氯倍他索 | Cort108297 |
密度 | 1.3±0.1 g/cm3 |
---|---|
沸点 | 580.1±50.0 °C at 760 mmHg |
熔点 | 274 – 275?C |
分子式 | C24H32O6 |
分子量 | 416.507 |
闪点 | 196.9±23.6 °C |
精确质量 | 416.219879 |
PSA | 93.06000 |
LogP | 2.62 |
外观性状 | 固体;White to Almost white powder to crystal |
蒸汽压 | 0.0±3.7 mmHg at 25°C |
折射率 | 1.598 |
储存条件 | Refrigerator |
地索奈德毒性英文版
|
危险品运输编码 | NONH for all modes of transport |
---|---|
海关编码 | 2937210000 |
~%
地索奈德
638-94-8
|
文献:Journal of the American Chemical Society, , vol. 81, p. 4573 |
海关编码 | 2937210000 |
---|
Prednacinolone |
(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one |
16a,17a-Isopropylidenedioxyprednisolone |
2H-naphth[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one, 4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-5-hydroxy-6b-(hydroxyacetyl)-4a,6a,8,8-tetramethyl-, (4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)- |
Desowen |
2H-Naphth[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one, 4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-5-hydroxy-6b-(2-hydroxyacetyl)-4a,6a,8,8-tetramethyl-, (4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)- |
Locapred |
Desonide |
(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacétyl)-4a,6a,8,8-tétraméthyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodécahydro-2H-naphto[2',1':4,5]indéno[1,2-d][1,3]dioxol-2-one |
Sterax |
11b,16a,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione Cyclic 16,17-Acetal with Acetone |
16a-Hydroxy-D1-hydrocortisone-16a,17a-acetonide |
16a-Hydroxyprednisolone-16a,17-acetonide |
Steroderm |
16a-Hydroxyprednisolone Acetonide |
TRIDESILON |
desonidum [INN_la] |
MFCD00866151 |
11β,16α,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone |
(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-Hydroxy-6b-(hydroxyacetyl)-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-on |
(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-6b-Glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one |
11b,21-Dihydroxy-16a,17-isopropylidenedioxy-1,4-pregnadiene-3,20-dione |
Topifug |
d-2083 |
EINECS 211-351-6 |
11,21-Dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione |
Budesonide Impurity 6 |